Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing QTc Interval Changes After Droperidol in Emergency Patients

Official title: Low-Dose Droperidol and Its Association with QTc Interval Changes in Emergency Department Patients

Run by CHRISTUS Health · NCT06726811 · Data updated 2026-11-12

This study is testing if giving low-dose Droperidol to emergency patients affects their heart rhythm by looking at changes in the QTc interval before and after treatment.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorCHRISTUS Health
Academic / other
Locations1 site (Corpus Christi, Texas)
StatusRecruiting
StartedOctober 17, 2024
Main results expectedSeptember 30, 2025
Study endsSeptember 30, 2026
Registry record updatedDecember 17, 2024
Trial IDNCT06726811 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adult emergency department patients aged 18 and older who are in a cardiovascular-monitored bed and have Droperidol ordered.

Probably not a fit

Patients who are unable to provide consent or have already received Droperidol before the ECG will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effects of low-dose Droperidol on QTc interval changes in patients treated in the emergency department. Adult patients aged 18 and older, who are in a cardiac-monitored bed and have an ECG performed, will receive 2.5 mg of IV Droperidol. ECGs will be recorded before and after the administration of Droperidol to assess any significant changes in the QTc interval. The primary outcome is to determine the percentage of patients experiencing a clinically significant increase in QTc after treatment.

Why it matters

Potential benefit: If successful, this study could provide insights into the safety of Droperidol regarding its effects on heart rhythm in emergency department patients.

How similar studies have gone: While there have been studies on Droperidol and QTc intervals, this specific observational approach to assess low-dose effects in an emergency setting is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ED patients ages 18 years or older in a cardiovascular-monitored bed who have both an ECG and a 2.5 mg dose of IV droperidol ordered by their treating physician will be eligible for inclusion.

Exclusion Criteria:

* Refusal to provide consent.
* Administration of droperidol before the first ECG is performed.
* Inability to complete the consent form and questionnaire due to clinical instability, severe pain, or disorientation as determined by a study physician.

Where it's running

  • CHRISTUS Spohn Hospital Corpus Christi-Shoreline
    Corpus Christi, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.